-
Something wrong with this record ?
Impact of Age on Predictive Capabilities of Ferritin, Ferritin-Hemoglobin Ratio, IL-6, and sIL-2R for COVID-19 Severity and Mortality
O. Skakun, Y. Vandzhura, I. Vandzhura, K. Symchych, A. Symchych
Language English Country Czech Republic
Document type Journal Article
Digital library NLK
Source
NLK
Directory of Open Access Journals
from 1997
Free Medical Journals
from 1997
Open Access Digital Library
from 1997-01-01
Medline Complete (EBSCOhost)
from 2012-06-01
ROAD: Directory of Open Access Scholarly Resources
from 1997
- MeSH
- Biomarkers * blood MeSH
- COVID-19 * mortality blood MeSH
- Ferritins * blood MeSH
- Hemoglobins analysis metabolism MeSH
- Interleukin-6 * blood MeSH
- Middle Aged MeSH
- Humans MeSH
- Predictive Value of Tests MeSH
- Receptors, Interleukin-2 blood MeSH
- SARS-CoV-2 MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Severity of Illness Index * MeSH
- Age Factors MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
The study aimed to establish the impact of age on the predictive capability of ferritin, ferritin-hemoglobin ratio (FHR), IL-6, and sIL-2R in COVID-19 patients. Compared to patients with moderate condition, patients with severe condition had higher ferritin level (441.0 [188.0-829.8] ng/mL vs 281.0 [172.0-388.0] ng/mL, p = 0.002), sIL-2R level (6.0 [4.7-9.0] pg/mL vs 5.3 [3.7-6.9] pg/mL, p = 0.020), FHR (38.4 [15.1-63.4] vs 22.0 [12.1-32.1], p = 0.002). The area under the curves (AUC) for discriminative capabilities of the following biomarkers for severe condition were assessed in patients aged <65 years and patients aged ≥65 years: ferritin (AUC = 0.585, p = 0.309 vs AUC = 0.683, p = 0.002), FHR (AUC = 0.589, p = 0.302 vs AUC = 0.688, p = 0.002), IL-6 (AUC = 0.503, p = 0.972 vs AUC = 0.647, p = 0.019), and sIL-2R (AUC = 0.549, p = 0.552 vs AUC = 0.646, p = 0.017). Also AUCs for discriminative capabilities for in-hospital mortality were compared in patients aged <65 years and ≥65 years: ferritin (AUC = 0.607, p = 0.628 vs AUC = 0.661, p = 0.105), FHR (AUC = 0.612, p = 0.621 vs AUC = 0.688, p = 0.002), IL-6 (AUC = 0.580, p = 0.724 vs AUC = 0.695, p = 0.016), and sIL-2R (AUC = 0.620, p = 0.491 vs AUC = 0.695, p = 0.029). Thus, ferritin, FHR, IL-6, and sIL-2R didn't show acceptable predictive value for severe condition and lethal outcome in patients aged <65 years but had high predictive value for lethal outcome in patients aged ≥65 years.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24020964
- 003
- CZ-PrNML
- 005
- 20250507135830.0
- 007
- ta
- 008
- 241105s2024 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.14712/18059694.2024.20 $2 doi
- 035 __
- $a (PubMed)39434671
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Skakun, Oleksii $u Clinic of St. Luka, Ivano-Frankivsk, Ukraine. olexiy109921@ukr.net
- 245 10
- $a Impact of Age on Predictive Capabilities of Ferritin, Ferritin-Hemoglobin Ratio, IL-6, and sIL-2R for COVID-19 Severity and Mortality / $c O. Skakun, Y. Vandzhura, I. Vandzhura, K. Symchych, A. Symchych
- 520 9_
- $a The study aimed to establish the impact of age on the predictive capability of ferritin, ferritin-hemoglobin ratio (FHR), IL-6, and sIL-2R in COVID-19 patients. Compared to patients with moderate condition, patients with severe condition had higher ferritin level (441.0 [188.0-829.8] ng/mL vs 281.0 [172.0-388.0] ng/mL, p = 0.002), sIL-2R level (6.0 [4.7-9.0] pg/mL vs 5.3 [3.7-6.9] pg/mL, p = 0.020), FHR (38.4 [15.1-63.4] vs 22.0 [12.1-32.1], p = 0.002). The area under the curves (AUC) for discriminative capabilities of the following biomarkers for severe condition were assessed in patients aged <65 years and patients aged ≥65 years: ferritin (AUC = 0.585, p = 0.309 vs AUC = 0.683, p = 0.002), FHR (AUC = 0.589, p = 0.302 vs AUC = 0.688, p = 0.002), IL-6 (AUC = 0.503, p = 0.972 vs AUC = 0.647, p = 0.019), and sIL-2R (AUC = 0.549, p = 0.552 vs AUC = 0.646, p = 0.017). Also AUCs for discriminative capabilities for in-hospital mortality were compared in patients aged <65 years and ≥65 years: ferritin (AUC = 0.607, p = 0.628 vs AUC = 0.661, p = 0.105), FHR (AUC = 0.612, p = 0.621 vs AUC = 0.688, p = 0.002), IL-6 (AUC = 0.580, p = 0.724 vs AUC = 0.695, p = 0.016), and sIL-2R (AUC = 0.620, p = 0.491 vs AUC = 0.695, p = 0.029). Thus, ferritin, FHR, IL-6, and sIL-2R didn't show acceptable predictive value for severe condition and lethal outcome in patients aged <65 years but had high predictive value for lethal outcome in patients aged ≥65 years.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a COVID-19 $x mortalita $x krev $7 D000086382
- 650 12
- $a ferritin $x krev $7 D005293
- 650 12
- $a interleukin-6 $x krev $7 D015850
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 12
- $a biologické markery $x krev $7 D015415
- 650 _2
- $a věkové faktory $7 D000367
- 650 12
- $a stupeň závažnosti nemoci $7 D012720
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a hemoglobiny $x analýza $x metabolismus $7 D006454
- 650 _2
- $a SARS-CoV-2 $7 D000086402
- 650 _2
- $a receptory interleukinu-2 $x krev $7 D015375
- 650 _2
- $a prediktivní hodnota testů $7 D011237
- 650 _2
- $a senioři nad 80 let $7 D000369
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Vandzhura, Yaroslava $u Ivano-Frankivsk National Medical University, Department of Internal Medicine #2 and Nursing, Ivano-Frankivsk, Ukraine
- 700 1_
- $a Vandzhura, Ihor $u Ivano-Frankivsk National Medical University, Department of Internal Medicine #2 and Nursing, Ivano-Frankivsk, Ukraine
- 700 1_
- $a Symchych, Khrystyna $u Ivano-Frankivsk National Medical University, Department of Therapy, Family and Emergency Medicine Postgraduate Education, Ivano-Frankivsk, Ukraine
- 700 1_
- $a Symchych, Anton $u Ivano-Frankivsk National Medical University, Department of General and Vascular Surgery, Ivano-Frankivsk, Ukraine
- 773 0_
- $w MED00010947 $t Acta Medica (Hradec Kralove) $x 1805-9694 $g Roč. 67, č. 2 (2024), s. 53-59
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39434671 $y Pubmed
- 910 __
- $a ABA008 $b A 3077 $c 1072 $y p $z 0
- 990 __
- $a 20241105 $b ABA008
- 991 __
- $a 20250507135827 $b ABA008
- 999 __
- $a ok $b bmc $g 2316507 $s 1232954
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 67 $c 2 $d 53-59 $e - $i 1805-9694 $m Acta medica (Hradec Kralove) $n Acta Medica (Hradec Kralove) $x MED00010947
- LZP __
- $b NLK124 $a Pubmed-20241105